Profile
Mr. Inderpal Singh is a General Counsel at Immunic, Inc. Mr. Singh was previously employed as a Head-Biopharma by Sandoz International GmbH, a Head-Global Manufacturing by Merck KGaA, and a Legal Director-Europe Division by Biogen Idec International GmbH.
He received his MBA from the University of Mannheim and an MBA from Insead Business School.
Inderpal Singh active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNIC, INC. | General Counsel | 01/06/2021 |
Former positions of Inderpal Singh
| Companies | Position | End |
|---|---|---|
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Corporate Officer/Principal | 01/06/2021 |
| MERCK KGAA | Corporate Officer/Principal | 01/01/2017 |
Biogen International GmbH
Biogen International GmbH Pharmaceuticals: MajorHealth Technology Produces pharmaceuticals | Corporate Officer/Principal | 01/01/2015 |
Training of Inderpal Singh
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
University of Mannheim
University of Mannheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen International GmbH
Biogen International GmbH Pharmaceuticals: MajorHealth Technology Produces pharmaceuticals | Health Technology |
Insead Business School
Insead Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Inderpal Singh
















